In vivo dendritic cell reprogramming for cancer immunotherapy
2024 · Science · 97 citations
https://doi.org/10.1126/science.adn9083
E
Emilie Renaud
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
24
Papers
456
Citations
9
h-index
9
i10-index
Emilie Renaud is an academic researcher from Inserm. The author has contributed to research in topics: DNA Repair Mechanisms & Immunotherapy and Immune Responses & Cancer-related Molecular Pathways. The author has an h-index of 9, co-authored 21 publications.
ORCID: 0000-0003-4747-1195Papers by this author
worksImpaired TIP60-mediated H4K16 acetylation accounts for the aberrant chromatin accumulation of 53BP1 and RAP80 in Fanconi anemia pathway-deficient cells
2015 · Nucleic Acids Research · 78 citations
https://doi.org/10.1093/nar/gkv1019
FANCD2 functions as a critical factor downstream of MiTF to maintain the proliferation and survival of melanoma cells
2016 · Scientific Reports · 43 citations
https://doi.org/10.1038/srep36539
Proteogenomics analysis unveils a TFG-RET gene fusion and druggable targets in papillary thyroid carcinomas
2020 · Nature Communications · 36 citations
https://doi.org/10.1038/s41467-020-15955-w
Additional file 3 of Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21311064
Additional file 4 of Multiomic analysis of papillary thyroid cancers identifies BAIAP2L1-BRAF fusion and requirement of TRIM25, PDE5A and PKCδ for tumorigenesis
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21311067
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat